These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13639583)

  • 1. A procedure for evaluating the antigenicity of killed virus vaccines for equine rhinopneumonitis.
    DOLL ER; BRYANS JT; McCOLLUM WH
    Cornell Vet; 1959 Apr; 49(2):212-20. PubMed ID: 13639583
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiologic study on an outbreak of acute respiratory disease among colts due to equine rhinopneumonitis virus.
    KAWAKAMI Y; KAJI T; ISHIZAKI R; SHIMIZU T; MATUMOTO M
    Jpn J Exp Med; 1962 Apr; 32():211-29. PubMed ID: 14031490
    [No Abstract]   [Full Text] [Related]  

  • 4. Epizootiology of equine viral rhinopneumonitis.
    DOLL ER; BRYANS JT
    J Am Vet Med Assoc; 1963 Jan; 142():31-7. PubMed ID: 14028462
    [No Abstract]   [Full Text] [Related]  

  • 5. [New virus vaccines].
    WESSLEN T
    Nord Med; 1962 Apr; 67():501-7. PubMed ID: 14006280
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral vectors for use in the development of biodefense vaccines.
    Lee JS; Hadjipanayis AG; Parker MD
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live virus immunizing agents.
    PRIER JE
    J Am Vet Med Assoc; 1960 Nov; 137():577-84. PubMed ID: 13737999
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the relations between the immunogenic activity of anti-virosis vaccines and their infectivity].
    PORTOCALA R
    Stud Cercet Inframicrobiol; 1960; 11():365-73. PubMed ID: 13737335
    [No Abstract]   [Full Text] [Related]  

  • 9. Infection immunity in equine virus abortion.
    DOLL ER; CROWE ME; BRYANS JT; McCOLLUM WH
    Cornell Vet; 1955 Jul; 45(3):387-410. PubMed ID: 14390961
    [No Abstract]   [Full Text] [Related]  

  • 10. A shot in the arm for immunotherapy.
    Griffiths PD
    Rev Med Virol; 2005; 15(4):215-7. PubMed ID: 15962359
    [No Abstract]   [Full Text] [Related]  

  • 11. New Cells for New Vaccines II: Focus on Respiratory Virus Diseases.
    Egan W; Schild G
    Biologicals; 2008 Nov; 36(6):345. PubMed ID: 18757211
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existing antiviral vaccines.
    Ravanfar P; Satyaprakash A; Creed R; Mendoza N
    Dermatol Ther; 2009; 22(2):110-28. PubMed ID: 19335723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live viral vaccines in patients with DiGeorge syndrome.
    Sullivan KE
    Clin Immunol; 2004 Oct; 113(1):3. PubMed ID: 15380522
    [No Abstract]   [Full Text] [Related]  

  • 16. Bibliography. Current world literature. Pathogenesis and immune response.
    Curr Opin Infect Dis; 2007 Jun; 20(3):329-44. PubMed ID: 17563953
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlates of immune protection and the development of a human immunodeficiency virus vaccine.
    Letvin NL
    Immunity; 2007 Sep; 27(3):366-9. PubMed ID: 17892845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of vaccine development. Introduction.
    Girard MP
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):73-5. PubMed ID: 17707507
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization of young horses against viral rhinopneumonitis.
    DOLL ER; BRYANS JT
    Cornell Vet; 1963 Jan; 53():24-41. PubMed ID: 14028463
    [No Abstract]   [Full Text] [Related]  

  • 20. A planned infection program for immunizing mares against viral rhinopneumonitis.
    DOLL ER; BRYANS JT
    Cornell Vet; 1963 Apr; 53():249-62. PubMed ID: 14028461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.